# Filing Signal Summary: ELV

### Stock Movement Analysis for ELV

#### Key Financial and Strategic Disclosures:

- **Earnings Announcement:**
  - Elevance Health, Inc. anticipates reporting first quarter 2025 GAAP shareholders' net income of $9.61 per diluted share, with adjusted net income at $11.97 per diluted share.
  - Notably, the first quarter results align with expected medical cost trends, especially within the Medicare Advantage business segment.

- **Outlook:**
  - The company reiterates its adjusted net income guidance for full year 2025 to range between $34.15 and $34.85 per diluted share.
  - Additionally, Elevance Health projects full-year 2025 Medicare Advantage membership to fall within the range of 2,200 to 2,250 thousand members.

- **Future Reporting:**
  - Detailed financial results for the first quarter and the full-year outlook are scheduled for release on April 22, 2025.

#### Investor Concerns:
Investors should closely monitor the upcoming earnings release on April 22, 2025, to gain deeper insights into Elevance Health, Inc.'s financial performance and strategic trajectory. Additionally, attention should be paid to any deviations from the provided earnings guidance and membership projections, particularly in the Medicare Advantage business segment.

## ðŸ“Š Market Reaction
The stock is currently trading at $424.78 as of 2025-04-20 22:53:36, a change of -2.36% from the previous sessionâ€™s close.

[ðŸ”— View 8-K Filing on SEC.gov](https://www.sec.gov/Archives/edgar/data/1156039/0001156039-25-000051-index.html)